Dietary fats altered nephrotoxicity profile of methylmercury in rats

Journal of Applied Toxicology

Volumn 29, Issue 2, 2009, Pages 126-140

  Jin, Xiaolei ^a   Lok, Eric ^a   Caldwell, Don ^a   Mueller, Rudi ^a   Kapal, Kamla ^a   Liston, Virginia ^a   Kubow, Stan ^b   Hing, Man Chan ^c   Mehta, Rekha ^a  

^a TOXICOLOGY RESEARCH DIVISION   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

Author keywords

Dietary fats; Methylmercury; Nephrotoxicity

Indexed keywords

4 AMINOHIPPURIC ACID; CREATININE; DOCOSAHEXAENOIC ACID; FISH OIL; LARD; MAGNESIUM; METHYLMERCURIC CHLORIDE; OIL; SEAL OIL; SOYBEAN OIL; TETRYLAMMONIUM; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FAT INTAKE; ION TRANSPORT; KIDNEY FUNCTION; KIDNEY MASS; MALE; NEPHROSIS; NEPHROTOXICITY; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SEAL; SPRAGUE DAWLEY RAT; URINE OSMOLALITY;

ANIMALS; BLOOD UREA NITROGEN; BODY WEIGHT; CALCIUM; CHOLESTEROL; CREATININE; DIET; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-GLUTAMYLTRANSFERASE; KIDNEY; MAGNESIUM; MALE; METABOLIC CLEARANCE RATE; METHYLMERCURY COMPOUNDS; NEPHROSIS; ORGAN SIZE; OSMOLAR CONCENTRATION; P-AMINOHIPPURIC ACID; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; TRIGLYCERIDES; URIC ACID;

RATTUS;

EID: 62849108228     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1389     Document Type: Article

References (91)

1. Agner E, Jans H. 1978. Mercury poisoning and nephrotic syndrome in two young siblings. Lancet 2(8096): 951.
2. Akyol T, Bulucu F, Sener O, Yamanel L, Aydin A, Volkan I, Bozoglu E, Demirkaya E, Eken A, Musabak U. 2007. Functions and oxidative stress status of leukocytes in patients with nephritic syndrome. Biol. Trace Element Res. 116: 237-247.
3. Alderman M, Redfern JS. 2004. Serum uric acid - a cardiovascular risk factor? Ther. Umsch. 61(9): 547-552.
4. Ballatori N, Wang W, Lieberman MW. 1998. Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. Am J. Pathol. 152(4): 1049-1055.
5. Barr RD, Smith H, Cameron HM. 1972. Tissue mercury levels in mercury-induced nephrotic syndrome. Am. J. Clin. Pathol. 59(4): 515-517.
6. Barregard L, Hultberg B, Schutz A, Sallsten G. 1988. Enzymuria in workers exposed to inorganic mercury. Int. Arch. Occup. Environ. Health. 61: 65-69.
7. Bartolome J, Grignolo A, Bartlome M, Trepanier P, Lerea L, Weigel S, Whitmore W, Michalopoulos G, Kavlock R, Slotkin T. 1985. Postnatal methylmercury exposure: effects on ontogeny of renal and hepatic ornithine decarboxylase responses to trophic stimuli. Toxicol. Appl. Pharmac. 80: 147-154.
8. Bland C, Rand MD. 2006. Methylmercury induces activation of Notch signaling. Neuro Toxicol. 27: 982-991.
9. Camici M. 2007. The nephrotic syndrome is an immunoinflammatory disorder. Med. Hypoth. 68(4): 900-905.
10. Chang LW, Ware RA, Desnoyers PA. 1973. A histochemical study on some enzyme changes in the kidney, liver, brain after chronic mercury intoxication in the rat. Food Cosmet. Toxicol. 11: 283-286.
11. Chapman L, Chan HM. 2000. The influence of nutrition on methylmercury intoxication. Environ. Health Perspect. 108(suppl. 1): 29-56.
12. Chen WJ, Body RL, Mottet NK. 1983. Biochemical and morphological studies of monkeys chronically exposed to methylmercury. J. Toxicol. Environ. Health 12: 407-416.
13. De Caterina R, Caprioli R, Giannessi D, Sicari R, Galli C, Lazzerini G, Bernini W, Carr L, Rindi P. 1993. n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int. 44(4): 843-850.
14. De Ceaurriz J, Payan JP, Morel G, Brondeau MT. 1994. Role of extracellular glutathione and gamma-glutamyltranspeptidase in the disposition and kidney toxicity of inorganic mercury in rats. J. Appl. Toxicol. 14(3):201-206.
15. Dogra GK, Herrmann S, Irish AB, Thomas MAB, Watts GF. 2002. Insulin resistance, Dyslipidemia, inflammation, and endothelial function in nephrotic syndrome. Nephrol. Dial. Transplant. 17: 2220-2225.
16. Ejaz AA, Mu W, Kang DH, Roncal C, Sautin YY, Henderson G, Tabah-Fisch I, Keller B, Beaver TM, Nakagawa T, Johnson RJ. 2007. Could uric acid have a role in acute renal failure? Clin. J. Am. Soc. Nephrol. 2(1): 16-21.
17. Eto K, Yasutake A, Miyammoto K-I, Tokunaga H, Otsuka Y. 1997. Chronic effects of methylmercury in rats. II. Pathological aspects. Tohoku, J. Exp. Med. 182: 197-205.
18. Fair PH, Dougherty WJ, Braddon SA. 1985. Methyl mercury and selenium interaction in relation to mouse kidney γ-glutamyltranspeptidase, ultrastructure, and function. Toxicol. Appl. Pharmac. 80: 78-96.
19. Folsom M, Fishbein L. 1972. Effects of repeated sub-lethal dosages of methylmercury in the rat. Sci. Tot. Environ. 1: 91-95.
20. Fowler BA, Woods JS. 1977. Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure. Exp. Mol. Pathol. 27: 403-412.
21. Fowler BA, Brown HW, Lucier GW, Krigman MR. 1975. The effects of chronic oral methylmercury exposure on lysosome system of rat kidney. Morphometric and biochemical studies. Lab. Invest. 32(3): 313-322.
22. Fujita T, Nakamura N, Kumasaka R, Shimada M, Murakami R, Osawa H, Yamabe H, Okumura K. 2006. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy. In Vivo 20(6B): 891-893.
23. Gerstner HB, Huff JE. 1977. Selected case histories and epidemiological examples of human mercury poisoning. Clin. Toxicol. 11(2): 131-150.
24. Gregus Z, Stein AF, Klaassen CD. 1987. Effect of inhibition of gammaglutamyl-transpeptidase on biliary and urinary excretion of glutathione-derived thiols and methylmercury. J. Pharmac. Exp. Ther. 242(1): 27-32.
25. Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T. 2007. Relationship between hyperuricemia and body fat distribution. Intern. Med. 46(17): 1353-1358.
26. Himeno S, Watanabe C, Suzuki T. 1986. Urinary Biochemical changes in workers exposed to mercury vapour. Ind. Health 24: 151-155.
27. Hirtsch GH. 1971. Inhibition of renal organic ion transport by methyl mercury. Environ. Physiol. 1: 51-54.
28. Højbjerg S, Nielsen JB, Andersen O. 1992. Effects of dietary lipids on whole-body retention and organ distribution of organic and inorganic mercury in mice. Food Chem. Toxicol. 30(8): 703-708.
29. Jalili MA, Abbasi AH. 1961. Poisoning by ethylmercury toluene sulphonanilide Br. J. Ind. Med. 18: 303-308.
30. Jin X, Lok E, Bondy G, Caldwell D, Meuller R, Kapal K, Armstrong C, Taylor M, Kubow S, Mehta R, Chan HM. 2007. Modulating effects of dietary fats on methylmercury toxicity and distribution in rats. Toxicology. 230(1): 22-44.
31. Jin X, Chan HM, Lok E, Kapal K, Taylor M, Kubow S, Mehta R. 2008. Dietary fats modulate methylmercury-mediated systemic oxidative stress and oxidative DNA damage in rats. Food Chem. Toxicol. 46: 1706-1720.
32. Johansen P, Mulvad G, Pedersen HS, Hansen JC, Riget F. 2007. Human accumulation of mercury in Greenland. Sci. Total Environ. 377: 173-178.
33. Kang DH, Nakagawa T. 2005. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol. 25(1): 43-49.
34. Kazantzis G. 2002. Mercury exposure and early effects: an overview. Med. Lav. 93(3): 139-147.
35. Kempson SA, Ellis BG, Price RG. 1977. Changes in rat renal cortex isolated plasma membranes and urinary enzymes following the injection of mercuric chloride. Chem. Biol. Interact. 18: 217-234.
36. Kevorkian J, Cento PD, Hyland JR, Bagozzi WM, van Hollebeke E. 1972. Mercury content of human tissues during the twentieth century. Am. J. Pub. Health 62(4): 504-513.
37. Kibukamusoke JW, Davies DR, Hutt MSR. 1974. Membranous nephropathy due to skin-lightening cream. Br. Med. J. 2: 646-647.
38. Klein R, Herman SR, Bulluck BC, Talley FA. 1973. Methylmercury intoxication in rat kidneys. Arch. Pathol. 96: 83-90.
39. Koh AS, Simmons-Willis TA, Pritchard JB, Grassl SM, Ballatori N. 2002. Identification of a mechanism by which methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1. Mol. Pharmac. 62(4): 921-926.
40. Kohn DF, Clifford CB. 2002. Biology and diseases of rat. In Laboratory Animal Medicine, Fox JG, Anderson LC, Loew FM, Quimby FW (eds). American College of Laboratory, Academic Press: San Diego, CA; 121-129.
41. Kronenberg F. 2005. Dyslipidemia and nephrotic syndrome recent advances. J. Renal Nutr. 15(2): 195-203.
42. Lenzi S, Caprioli R, Rindi P, Lazzerini G, Bernini W, Pardini E, Lucchetti A, Galli C, Carr L, De Caterina R. 1996. Omega-3 fatty acid supplementation and lipoprotein(a) concentrations in patients with chronic glomerular diseases. Nephron 72(30): 383-390.
43. Lillie LE, Temple NJ, Florence LZ. 1996. Reference values for young normal Sprague-Dawley rats: weight gain, haematology, and clinical chemistry. Hum. Exp. Toxicol. 15(8): 612-616.
44. Lu J, Bankovic-Calic N, Ogborn M, Saboorian MH, Aukema HM. 2003. Detrimental effects of high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats. J. Nutr. 133: 180-186.
45. Madsen KM, Christensen EI. 1978. Effects of mercury on lysosomal protein digestion in the kidney proximal tubule. Lab. Invest. 38(2): 165-174.
46. Mangos L, Peristianis GG, Clarkson TW, Brown A, Preston S, Snowden RT. 1981. Comparative study of the sensitivity of male and female rats to methylmercury. Arch. Toxicol. 48: 11-20.
47. Meeks A, Keith PR, Tanner MS. 1990. Nephrotic syndrome in two membranes of a family with mercury poisoning. J. Trace Elem. Electrolytes Health Dis. 4(4): 237-239.
48. Michaud A, Sapin C, Leca G, Aiach M, Druet P. 1984. Involvement of hemostasis during an autoimmune glomerulonephritis induced by mercury chloride in brown Norway rats. Thromb. Res. 33(1): 77-88.
49. Munro IC, Nera EA, Charbonneau SM, Junkins B, Zawidzka Z. 1980. Chronic toxicity of methylmercury in the rat. J. Environ. Pathol. Toxicol. 3: 437-447.
50. Nakano M, Itoh G. 1983. Elevation of urinary trehalase in mercuric chloride-induced nephrotoxic rabbits: urinary trehalase as a specific indicator of renal brush border damage. Chemico-Biol. Interact. 45: 179-189.
51. National Research Council. 1995. Nutrient requirements of laboratory rats. In Nutrient Requirements of Laboratory Animals, 4th edn (revised). National Academy of Sciences: Washingdon, DC; 11-79.
52. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema HM. 2002. Dietary flaxoil reduced renal injury, oxidized LDL content, and tissue n-6/n3 FA ratio in experimental polycystic kidney disease. Lipids 37(11): 1059-1065.
53. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema HM. 2006. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender. Lipids 41(12): 1141-1149.
54. Ohi G, Hishigki S, Seki H, Tamura Y, Maki T, Konno H, Ochiai S, Yamada H, Shimamura Y, Mizoguchi I, Yagyu H. 1976. Efficacy of selenium in tuna and selenite in modifying methylmercury intoxication. Environ. Res. 12: 49-58.
55. Ohno T, Sakamoto M, Kurosawa T, Dakeishi M, Iwata T, Murata K. 2007. Total mercury level in hair, toenail, and urine among women free from occupational exposure and their relations to renal tubular function. Environ. Res. 103: 191-197.
56. Ohtake T, Kimura M, Takemura H, Hishida A. 2002. Effects of dietary lipids on daunomycin-induced nephropathy in mice: comparison between cod liver oil and soybean oil. Lipids 37(4): 359-366.
57. Pelis RM, Dangprapai Y, Wunz TM, Wright SH. 2007. Inorganic mercury interacts with cysteine residues (C451 and C474) of hOCT2 to reduce its transport activity. Am. J. Physiol. Renal Physiol. 292(5): F1583-1591.
58. Perrone RD, Madias NE, Levey AS. 1992. Serum creatinine as an index of renal function: new insights into old concepts. Clin.Chem. 38(10): 1933-1953.
59. Ragan HA, Weller RE. 1999. Chapter Sixteen: Markers of renal function and injury. In The Clinical Chemistry of Laboratory Animals, Loeb WF, Quimby FW (eds). Taylor and Francis: Philadelphia, PA; 519-545.
60. Sakamoto M, Wakisaka I, Ando T, Yanagihashi T. 1988. Effects of dietary lipids on lipid peroxidation and the accumulation of mercury in rat tissues. Jpn. J. Hyg. 43(4): 917-922.
61. Sankaran D, Lu J, Bankovic-calic N, Ogborn MR, Aukema HM. 2004. Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat. Lipids. 39(3): 207-214.
62. Sener S, Braun JP, Rico AG, Benard P, Burgat-Sacaze V. 1979. Urinary gamma-glutamyl transpeptidase in rat kidney toxicology: nephropathy by repeated injections of mercuric chloride. Effects of sodium selenite. Toxicology 12(3): 299-305.
63. Shevock PN, Khan SR, Hackett RL. 1993. Urinary chemistry of the normal Sprague-Dawley rat. Urol. Res. 21: 309-312.
64. Shull RM, Stowe CM, Osborne CA, O'Leary TP, Vernier RL, Hammer RF. 1981. Membranous glomerulonephropathy and nephritic syndrome associated with iatrogenic metallic mercury poisoning in a cat. Vet. Hum. Toxicol. 23(1): 1-5.
65. Slotkin TA, Pachman S, Bartolome J, Kavlock RJ. 1985. Biochemical and functional alterations in renal and cardiac development resulting from neonatal methylmercury treatment. Toxicology 36: 231-241.
66. Slotkin TA, Kavlock RJ, Cowdery T, Orband L, Bartolome M, Whitmore WL, Barttolome J. 1986a. Effects of neonatal methylmercury exposure on adrenergic receptor binding sites in peripheral tissues of developing rat. Toxicology 41: 95-106.
67. Slotkin TA, Kavlock RJ, Cowdery T, Orband L, Bartolome M, Barttolome M, Gray JA, Rehnberg BF, Barttolome J. 1986b. Functional consequences of prenatal methylmercury exposure: effects on renal and hepatic responses to trophic stimuli and on renal excretory mechanisms. Toxicol. Lett. 34(2-3): 231-245.
68. Stroo WE, Hook JB. 1977. Renal function correlates of methyl mercury intoxication: interaction with acute mercuric chloride toxicity. Toxicol. Appl. Pharmac. 42: 399-410.
69. Sulikowska B, Nieweglowski T, Manitius J, Lysiak-Szydlowska W, Rutkowski B. 2004. Effect of 12-month therapy with omega-3 polyunsaturated acids on glomerular filtration response to dopamine in IgA nephropathy. Am. J. Nephrol. 24(5): 474-482.
70. Suzuki CA, Hierlihy L, Barker M, Curran I, Mueller R, Bondy GS. 1995. The effects of fumonisin B1 on several markers of nephrotoxicity in rats. Toxicol. Appl. Pharmac. 133(2): 207-214.
71. Takeda M, Hosoyamada M, Cha SH, Sekine T, Endou H. 2000. Hydrogen peroxide downregulates human organic anion transporters in the basolateral membrane of the proximal tubule. Life Sci. 68(6): 79-87.
72. Takeuchi T. 1970. Biological reactions and pathological changes of human beings and animals under the condition of organic mercury contamination. International Conference on Environmental Mercury Contamination, Ann Arbor, MI, 1970.
73. Tamashiro H, Akagi H, Futatsuka M, Roht LH. 1984. Causes of death in Minamata disease: analysis of death certificates. Int. Arch. Occup. Environ. Health 54(2): 135-146.
74. Tamashiro H, Arakaki M, Akagi H, Futatsuka M, Roht LH. 1985. Mortality and survival for Minamata disease. Int. J. Epidemiol. 14(4): 582-588.
75. Tamashiro H, Arakaki M, Futatsuka M, Lee ES. 1986. Methylmercury exposure and mortality in southern Japan: a close look at causes of death. J. Epidemiol. Comm. Health 40: 181-185.
76. Tanaka T, Naganuma A, Imura N. 1992. Routes for renal transport of methylmercury in mice. Eur. J. Pharmac. 228(1): 9-14.
77. Tang HL, Chu KH, Mak YF, Lee W, Cheuk A, Yim KS, Fung HW, Chan KL. 2006. Minimal change disease following exposure to mercury-containing skin lightening cream. Hong Kong Med. J. 12(4): 316-318.
78. Trof RJ, Di Maggio F, Leemreis J, Groeneveld ABJ. 2006. Biomarkers of acute renal injury and renal failure. Shock 26(3): 245-253.
79. Tubbs RR, Gephardt GN, McMahon JT, Pohl MC, Vidt DG, Barenerg SA, Valenzuela R. 1982. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am. J. Clin. Pathol. 77(4): 409-413.
80. Verschuuren HG, Kroes R, Tonkelaar EMD, Berkvens JM, Helleman PW, Rauws AG, Schuller PL, Van Esch GJ. 1976a. Toxicity of methylmercury chloride in rats: I. Short-term study. Toxicology 6: 85-96.
81. Verschuuren HG, Kroes R, Tonkelaar EMD, Berkvens JM, Helleman PW, Rauws AG, Schuller PL, Van Esch GJ. 1976b. Toxicity of methylmercury chloride in rats: II. Reproduction study. Toxicology 6: 85-96.
82. Verschuuren HG, Kroes R, Tonkelaar EMD, Berkvens JM, Helleman PW, Rauws AG, Schuller PL, Van Esch GJ. 1976c. Toxicity of methylmercury chloride in rats: III. Long-term toxicity study. Toxicology 6: 107-123.
83. Ware RA, Burkholder PM, Chang LW. 1975. Ultrastructural changes in renal proximal tubules after chronic organic and inorganic mercury intoxication. Environ. Res. 10: 121-140.
84. Watanabe M, Nomura G, Hirata G, Imai K, Koizumi H. 1980. Studies on the validity of urine enzyme assay in the diagnosis of drug induced renal lesions in rats. Toxicol. Pathol. 8: 22-23.
85. WHO. 2000. Safety Evaluation of Certain Food Additives and Contaminants. WHO Food Additives Series: 44, Methylmercury. WHO: Geneva; 1-77.
86. Yasutake A, Hirayama K, Inouye M. 1990. Sex difference in acute renal dysfunction induced by methylmercury in mice. Renal Fail. 12(4): 233-240.
87. Yasutake A, Nakano A, Mivamoto K, Eto K. 1997. Chronic effects of methylmercury in rats. I. Biochemical Aspects. Tohokn J. Exp. Med. 182: 185-196.
88. Yo S, Chow KM, Lam CW, Lai FM, Szeto CC, Chan MH, Li PK. 2003. A whitened face woman with nephrotic syndrome. Am. J. Kidney Dis. 41(1): 250-253.
89. Zalme RC, McDowell EM, Nagle RB, McNeil JS, Flamenbaum W, Trump BF. 1976. Studies on the pathophysiology of acute renal failure. II. A histochemical study of the proximal tubule of the rat following administration of mercuric chloride. Virchows Arch. B Cell Pathol. 22(3): 197-216.
90. Zalups RK. 2000. Molecular interactions with mercury in kidney. Pharmac. Rev. 52(1), 113-143.
91. Zalups RK, Ahmad S. 2005. Transport of N-acetylcysteine s-conjugates of methylmercury in Madin-Darby canine kidney cells stably transfected with human isoform of organic anion transporter 1. J. Pharmac. Exp. Ther. 314(3): 1158-1168.